CorMedix Inc. — Director's Dealing 2015

Mar 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2015-03-02

Reporting Person: Markvicka Taunia (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-02	Stock Option (right to buy)	$5.62	A	50000	Acquired	2025-03-01	Common Stock, $0.001 par value per share (50000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.05	2024-04-03	Common Stock, $0.001 par value per share (30000)	30000	Direct

Footnotes

F1: These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.

F2: The options vest in full on the first anniversary of the date of grant.